US congressman demands probe into FDA’s handling of heparin scare
This article was originally published in SRA
Executive Summary
A US congressman has asked the Government Accountability Office to conduct a thorough review of the Food and Drug Administration’s investigation into patient deaths associated with the use of contaminated heparin imported from China in 20081,2.